Page last updated: 2024-09-04

edotreotide and Astrocytoma, Grade IV

edotreotide has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Freitag, P; Gratzl, O; Hausmann, O; Jermann, E; Mäcke, HR; Merlo, A; Müller-Brand, J; Otte, A; Reubi, JC; Steiner, P; Wasner, M	1

Trials

1 trial(s) available for edotreotide and Astrocytoma, Grade IV

Article	Year
Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5 Topics: Adult; Astrocytoma; Binding, Competitive; Brain Edema; Brain Neoplasms; Diffusion; Disease Progression; Female; Glioblastoma; Glioma; Humans; Injections, Intralesional; Male; Middle Aged; Neoplasm Proteins; Octreotide; Oligodendroglioma; Pilot Projects; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Stereotaxic Techniques; Tissue Distribution; Ytterbium	1999

Article

Year

Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5

Topics: Adult; Astrocytoma; Binding, Competitive; Brain Edema; Brain Neoplasms; Diffusion; Disease Progression; Female; Glioblastoma; Glioma; Humans; Injections, Intralesional; Male; Middle Aged; Neoplasm Proteins; Octreotide; Oligodendroglioma; Pilot Projects; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Stereotaxic Techniques; Tissue Distribution; Ytterbium

1999